| | | | | | | | | | |
|
| |
|
| Dockets Entered
On September 15, 2005
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
|
|
| 1999P-4613
|
| Revoke the Regulation That Approved Posilac
|
|
|
|
|
| 2000D-1598
|
| Voluntary Labeling for Bioengineered Foods
|
|
|
|
|
| 2000N-1396
|
| Bioengineered Foods Consumed By Humans or Animals
|
|
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| 2004D-0251
|
| Requests for Inspection by an Accredited Person under the Inspections by Accredited Persons Program Authorized by Section 201 of the Medical Device User Fee and Modernization Act of 2002
|
|
|
|
|
| 2004H-0322
|
| Civil Money Penalty Re: Ecumed Health Group, Inc.
|
|
|
|
|
| 2004N-0486
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Experimental Study of Health Claims on Food Packages
|
|
|
|
|
| 2005D-0348
|
| Guidance for Industry and Food and Drug Administration: Procedures for Handling Post-Approval Studies Imposed by PMA Order
|
|
|
|
|
| 2005N-0279
|
| Food Labeling; Gluten-Free Labeling of Foods; Public Meeting
|
|
|
|
|
| 2005N-0345
|
| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
|
|
|
|
|
| 2005P-0139
|
| withdrawal of approvals of certain herdwide/flockwide uses of critically and highly important antibiotics pursuant to guidance #152
|
|
|
|
|
| 2005P-0282
|
| Require Health Messages on Soft Drinks
|
|
| |
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
|
|
| EMC 610
|
| F Eaton
|
| Vol #:
|
| 24
|
|
|
|
|
| 1999P-4613
|
| Revoke the Regulation That Approved Posilac
|
|
|
|
|
| EMC 2430
|
| L Blue
|
| Vol #:
|
| 46
|
|
|
|
|
| 2000D-1598
|
| Voluntary Labeling for Bioengineered Foods
|
|
|
|
|
| C 10010
|
| R Davis
|
| Vol #:
|
| 580
|
|
|
|
|
| 2000N-1396
|
| Bioengineered Foods Consumed By Humans or Animals
|
|
|
|
|
| C 9617
|
| R Davis
|
| Vol #:
|
| 415
|
|
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
|
|
| C 301
|
| G Guarton
|
| Vol #:
|
| 271
|
|
|
|
|
| EMC 797
|
| J A Beard
|
| Vol #:
|
| 271
|
|
| |
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| EMC 522
|
| H J Roberts MD
|
| Vol #:
|
| 8
|
|
|
|
|
| EMC 523
|
| H J Roberts MD
|
| Vol #:
|
| 8
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| EMC 1115
|
| P Bronson
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 1116
|
| R Berson
|
| Vol #:
|
| 11
|
|
